(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-0.15%) $77.99
(0.37%) $2.15
(0.06%) $2 310.10
(0.36%) $26.79
(0.09%) $966.20
(-0.34%) $0.929
(-1.23%) $10.86
(-0.14%) $0.797
(0.52%) $91.61
Live Chart Being Loaded With Signals
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software...
Stats | |
---|---|
आज की मात्रा | 4.99M |
औसत मात्रा | 6.34M |
बाजार मूल्य | 108.47B |
EPS | $0 ( 2024-04-07 ) |
अगली कमाई की तारीख | ( $1.450 ) 2024-05-23 |
Last Dividend | $0.690 ( 2023-09-21 ) |
Next Dividend | $0 ( N/A ) |
P/E | 25.93 |
ATR14 | $0.0310 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Powell Kendall J | Sell | 192 | Ordinary Shares |
2024-05-01 | Oleary Denise M | Sell | 192 | Ordinary Shares |
2024-05-01 | Nabel Elizabeth G | Sell | 192 | Ordinary Shares |
2024-05-01 | Lofton Kevin E | Sell | 192 | Ordinary Shares |
2024-05-01 | Hogan Randall J | Sell | 192 | Ordinary Shares |
INSIDER POWER |
---|
70.98 |
Last 100 transactions |
Buy: 1 291 792 | Sell: 191 147 |
मात्रा सहसंबंध
Medtronic PLC सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Medtronic PLC सहसंबंध - मुद्रा/वस्त्र
Medtronic PLC वित्तीय
Annual | 2023 |
राजस्व: | $31.23B |
सकल लाभ: | $20.51B (65.67 %) |
EPS: | $2.85 |
FY | 2023 |
राजस्व: | $31.23B |
सकल लाभ: | $20.51B (65.67 %) |
EPS: | $2.85 |
FY | 2023 |
राजस्व: | $31.23B |
सकल लाभ: | $20.51B (65.67 %) |
EPS: | $2.83 |
FY | 2022 |
राजस्व: | $31.69B |
सकल लाभ: | $21.54B (67.98 %) |
EPS: | $3.75 |
Financial Reports:
No articles found.
Medtronic PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.680 (N/A) |
$0.680 (N/A) |
$0.680 (N/A) |
$0.690 (N/A) |
$0.690 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00219 | 1982-01-04 |
Last Dividend | $0.690 | 2023-09-21 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-13 | |
Next Payout Date | N/A | |
# dividends | 167 | -- |
Total Paid Out | $27.99 | -- |
Avg. Dividend % Per Year | 1.62% | -- |
Score | 5.08 | -- |
Div. Sustainability Score | 9.19 | |
Div.Growth Potential Score | 3.66 | |
Div. Directional Score | 6.43 | -- |
Year | Amount | Yield |
---|---|---|
1982 | $0.00938 | 1.55% |
1983 | $0.0106 | 1.26% |
1984 | $0.0116 | 1.72% |
1985 | $0.0122 | 2.89% |
1986 | $0.0131 | 1.94% |
1987 | $0.0150 | 1.24% |
1988 | $0.0134 | 0.90% |
1989 | $0.0203 | 1.67% |
1990 | $0.0238 | 1.16% |
1991 | $0.0286 | 1.09% |
1992 | $0.0325 | 0.56% |
1993 | $0.0387 | 0.65% |
1994 | $0.0595 | 1.15% |
1995 | $0.0454 | 0.68% |
1996 | $0.0802 | 0.62% |
1997 | $0.103 | 0.61% |
1998 | $0.120 | 0.48% |
1999 | $0.145 | 0.40% |
2000 | $0.181 | 0.53% |
2001 | $0.215 | 0.36% |
2002 | $0.299 | 0.60% |
2003 | $0.280 | 0.60% |
2004 | $0.243 | 0.50% |
2005 | $0.362 | 0.73% |
2006 | $0.413 | 0.71% |
2007 | $0.470 | 0.89% |
2008 | $0.813 | 1.64% |
2009 | $0.598 | 1.83% |
2010 | $0.860 | 1.96% |
2011 | $0.936 | 2.50% |
2012 | $1.266 | 3.27% |
2013 | $1.100 | 2.63% |
2014 | $1.195 | 2.09% |
2015 | $1.445 | 2.01% |
2016 | $1.670 | 2.20% |
2017 | $1.810 | 2.56% |
2018 | $1.460 | 1.78% |
2019 | $2.12 | 2.41% |
2020 | $2.28 | 1.99% |
2021 | $2.47 | 2.13% |
2022 | $2.67 | 2.52% |
2023 | $2.06 | 2.63% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.130 | 1.500 | 7.40 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0462 | 1.200 | 8.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0816 | 1.500 | -0.204 | -0.307 | [0.1 - 1] |
payoutRatioTTM | 0.871 | -1.000 | 1.293 | -1.293 | [0 - 1] |
currentRatioTTM | 2.30 | 0.800 | 3.51 | 2.80 | [1 - 3] |
quickRatioTTM | 1.459 | 0.800 | 6.12 | 4.90 | [0.8 - 2.5] |
cashRatioTTM | 0.166 | 1.500 | -0.190 | -0.286 | [0.2 - 2] |
debtRatioTTM | 0.277 | -1.500 | 5.39 | -8.08 | [0 - 0.6] |
interestCoverageTTM | 8.05 | 1.000 | 8.13 | 8.13 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.15 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.485 | -1.500 | 8.06 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.655 | 1.000 | 2.42 | 2.42 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.175 | 1.000 | 8.50 | 8.50 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.258 | 1.000 | 9.68 | 9.68 | [0.2 - 2] |
assetTurnoverTTM | 0.356 | 0.800 | -0.961 | -0.769 | [0.5 - 2] |
Total Score | 9.19 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.86 | 1.000 | 7.49 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0816 | 2.50 | -0.131 | -0.307 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.76 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.38 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.871 | 1.500 | 1.293 | -1.293 | [0 - 1] |
pegRatioTTM | -1.054 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.200 | 1.000 | 7.50 | 0 | [0.1 - 0.5] |
Total Score | 3.66 |
Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं